VIR (STOCKS)
Vir Biotechnology, Inc. Common Stock
$8.645700
+0.035700 (+0.41%)
Prev close: $8.610000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Marianne de Backer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,451.25M
- Employees
- 408
- P/E (TTM)
- -2.74
- P/B (TTM)
- 1.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.85 | $-0.10 | -0.7536 | -781.74% |
|
Dec 2025 (Q4)
|
$-0.31 | $-0.50 | +0.1865 | +37.56% |
|
Sep 2025 (Q3)
|
$-1.17 | $-0.86 | -0.3078 | -35.70% |
|
Jun 2025 (Q2)
|
$-0.80 | $-0.73 | -0.0693 | -9.48% |
Financial Statements
| Revenues | $65.50M |
| Benefits Costs and Expenses | $507.84M |
| Costs And Expenses | $537.57M |
| Nonoperating Income/Loss | $29.73M |
| Operating Expenses | $537.53M |
| Selling, General, and Administrative Expenses | $91.47M |
| Research and Development | $446.24M |
| Operating Income/Loss | -$472.07M |
| Income/Loss From Continuing Operations After Tax | -$442.72M |
| Income/Loss From Continuing Operations Before Tax | -$442.35M |
| Income Tax Expense/Benefit | $371.00K |
| Net Income/Loss | -$442.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$442.72M |
| Net Income/Loss Available To Common Stockholders, Basic | -$442.72M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.12 |
| Diluted Earnings Per Share | -$3.12 |
| Basic Average Shares | 424,967,339 |
| Diluted Average Shares | 424,967,339 |
| Assets | $1.03B |
| Current Assets | $522.99M |
| Noncurrent Assets | $502.60M |
| Fixed Assets | $53.16M |
| Intangible Assets | $7.78M |
| Other Non-current Assets | $441.67M |
| Liabilities | $212.82M |
| Current Liabilities | $73.56M |
| Accounts Payable | $5.45M |
| Other Current Liabilities | $68.11M |
| Noncurrent Liabilities | $139.26M |
| Equity | $812.77M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $812.77M |
| Liabilities And Equity | $1.03B |
| Net Cash Flow From Operating Activities | -$446.05M |
| Net Cash Flow From Operating Activities, Continuing | -$446.05M |
| Net Cash Flow From Investing Activities | $195.39M |
| Net Cash Flow From Investing Activities, Continuing | $195.39M |
| Net Cash Flow From Financing Activities | $165.71M |
| Net Cash Flow From Financing Activities, Continuing | $165.71M |
| Net Cash Flow | -$84.95M |
| Net Cash Flow, Continuing | -$84.95M |
| Comprehensive Income/Loss | -$444.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$444.23M |
| Other Comprehensive Income/Loss | -$6.24M |